ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Apr 08, 2015 11:00 JST
Source:
LinguaNext
LinguaNext Technologies' 'Linguify.S' becomes a SAP-Endorsed Business Solution
Linguify.S integrated with SAP(R) applications to give SAP customers additional local language deployment options
PUNE, India, Apr 08, 2015 - (ACN Newswire) - LinguaNext Technologies today announced that its language platform Linguify.S is now an SAP-endorsed business solution for all countries worldwide. SAP will continue to develop localized versions for selected on-premise or cloud solutions, while LinguaNext will offer complementary solutions for product and language combinations not covered by SAP.
LinguaNext a SAP Partner
Linguify.S makes no changes or modifications to the underlying SAP(R) software or application databases. Instead, language conversion is handled externally at the display level, with all screen output translated in real time using a customized in-memory dictionary. This allows customers to run a single language instance of an SAP application across multiple regions, with users in each country selecting their preferred display language from a drop-down menu.
Solutions endorsed by SAP SE are complementary to SAP software offerings, have been specifically integrated with SAP solutions and tested by SAP, and provide additional choices and flexibility for businesses running SAP software.
"Companies are increasingly realizing the benefits of providing their staff, their partners and customers in each country with business applications in their native language," says LinguaNext CEO and co-founder Jagdish Sahasrabudhe. "Surveys clearly show that employee productivity and customer engagement levels are much higher when user interfaces and e-commerce platforms are provided in the local language of the country."
Added Sahasrabudhe, "The LinguaNext solution dramatically reduces the cost, complexity, deployment and time to market of local language enablement of business applications. We are delighted to have received this global endorsement from SAP, the world's leading provider of enterprise application software."
Said VR Ferose, managing director, SAP Globalization Services, "As the SAP solution portfolio continues to expand and customer demand for local language increases, we have been looking at innovative new ways to deliver local language that will complement SAP's own efforts and give our customers more choice. Having endorsed the LinguaNext solution two years ago for selected markets and solutions, we felt very confident expanding the partnership to markets and products worldwide."
About LinguaNext
LinguaNext is a market leader in enterprise application language management and is transforming the way global corporations, software application vendors and leading system integrators address multi-language and local language support for information technology systems. With a roster of over 200 global customers, LinguaNext is fast becoming the standard language platform across a wide range of vertical markets. LinguaNext's innovative technology-based solutions enable enterprise, mobile or cloud software systems to work in any language, with zero changes to the underlying application code or database. This approach helps reduce complexity, lower costs and deliver fast time to usability for IT systems. LinguaNext is headquartered in Pune, India and is funded by Helion Venture Partners.
About SAP-Endorsed Business Solutions
SAP-endorsed business solutions are complementary to SAP software offerings, have been specifically integrated with SAP solutions and tested by SAP, and provide additional choices and flexibility for businesses running SAP software. SAP-endorsed business solutions are offered by SAP partners.
For more information, please contact:
Ms. Ashwini Deshpande
LinguaNext Technologies Pvt. Ltd.
ashwini.deshpande@linguanext.net
+91 77 74 00 09 64
Source: LinguaNext
Sectors: Retail & eCommerce, Cloud & Enterprise, E-commerce, Consumer Electronics
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
Revenue of LEQEMBI(R) (Preliminary Basis)
Jul 31, 2025 18:27 JST
Transfer of Sharp Mie Plant No.2 and part of the land at Mie Base
Jul 31, 2025 17:11 JST
TANAKA PRECIOUS METAL GROUP Announces Business Partnership with JEPLAN to Realize a Decarbonized, Circular Society
Jul 31, 2025 15:00 JST
DENSO Announces First Quarter Financial Results
Jul 31, 2025 11:25 JST
Honda Launches All-New Prelude Teaser Page Ahead of Scheduled September 2025 Market Introduction
Jul 31, 2025 11:20 JST
MHI Demonstrates Transport of Relief Supplies in the Event of a Disaster Using Uncrewed Aerial Vehicles Currently in Development
Jul 31, 2025 11:00 JST
Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI(R) (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
Jul 31, 2025 09:30 JST
New Data Presented at AAIC Demonstrates Investigational LEQEMBI(R) (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease
Jul 31, 2025 09:20 JST
Two-Year Real-World Study of LEQEMBI(R) in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
Jul 31, 2025 09:10 JST
Introducing the Meshy 5 Preview: Smarter AI, Cleaner Models, Bigger Animation Potential
Jul 30, 2025 22:41 JST
Production, Sales and Export Results for June, 2025
Jul 30, 2025 18:24 JST
Sales, Production, and Export Results for the First Half of 2025
Jul 30, 2025 18:06 JST
Collaborative Development of Ultra-Compact and Lightweight Satellite Communication User Terminals for Mobility with Mitsubishi Chemical, NICT, and TECHLAB
Jul 30, 2025 11:00 JST
Mitsubishi Heavy Industries Concludes Agreement with Modius to Provide DCIM Solutions for Data Centers Worldwide
Jul 29, 2025 20:00 JST
Set at the Osaka-Kansai Expo venue! Detailed program announced for the "OSAKA JAPAN SDGs Forum"
Jul 29, 2025 14:30 JST
LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma
Jul 29, 2025 09:01 JST
Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics
Jul 25, 2025 16:00 JST
Eisai Listed for 24th Consecutive Year in FTSE4Good Index Series, an Index for Socially Responsible Investment
Jul 25, 2025 13:31 JST
Fujitsu and Nagoya University develop simulation tech to combat transportation gaps
Jul 24, 2025 12:30 JST
Honda Reveals Details of its Support of the World Athletics Championships Tokyo 25
Jul 24, 2025 12:03 JST
More Latest Release >>